NDC Codes Similar to 49281-541-15 Code

49281-541-15 – Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated)

19515-895-11 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 1 VIAL, MULTI-DOSE in 1 CARTON (19515-895-11) > 5 mL in 1 VIAL, MULTI-DOSE (19515-895-01) TXT \| PDF \| XML \| JSON	58160-900-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-900-52) > .5 mL in 1 SYRINGE (58160-900-41) TXT \| PDF \| XML \| JSON
19515-816-52 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 10 SYRINGE in 1 CARTON (19515-816-52) > .5 mL in 1 SYRINGE (19515-816-41) TXT \| PDF \| XML \| JSON	19515-818-52 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 10 SYRINGE in 1 CARTON (19515-818-52) > .5 mL in 1 SYRINGE (19515-818-41) TXT \| PDF \| XML \| JSON
58160-885-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-885-52) > .5 mL in 1 SYRINGE (58160-885-41) TXT \| PDF \| XML \| JSON	58160-887-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-887-52) > .5 mL in 1 SYRINGE (58160-887-41) TXT \| PDF \| XML \| JSON
19515-808-52 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 10 SYRINGE in 1 CARTON (19515-808-52) > .5 mL in 1 SYRINGE (19515-808-41) TXT \| PDF \| XML \| JSON	58160-890-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-890-52) / .5 mL in 1 SYRINGE (58160-890-41) TXT \| PDF \| XML \| JSON
19515-814-52 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 10 SYRINGE in 1 CARTON (19515-814-52) / .5 mL in 1 SYRINGE (19515-814-41) TXT \| PDF \| XML \| JSON	58160-909-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-909-52) / .5 mL in 1 SYRINGE (58160-909-41) TXT \| PDF \| XML \| JSON
49288-0338-1 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 2 mL in 1 VIAL, MULTI-DOSE (49288-0338-1) TXT \| PDF \| XML \| JSON	49288-0338-2 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 5 mL in 1 VIAL, MULTI-DOSE (49288-0338-2) TXT \| PDF \| XML \| JSON
49288-0338-3 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0338-3) TXT \| PDF \| XML \| JSON	49288-0338-4 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 30 mL in 1 VIAL, MULTI-DOSE (49288-0338-4) TXT \| PDF \| XML \| JSON
49288-0338-5 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 50 mL in 1 VIAL, MULTI-DOSE (49288-0338-5) TXT \| PDF \| XML \| JSON	49281-226-65 – Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) Firm: Sanofi Pasteur Inc. Package Description: 10 SYRINGE, GLASS in 1 PACKAGE (49281-226-65) / .7 mL in 1 SYRINGE, GLASS (49281-226-88) TXT \| PDF \| XML \| JSON
49281-326-50 – Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) Firm: Sanofi Pasteur Inc. Package Description: 10 SYRINGE, GLASS in 1 PACKAGE (49281-326-50) / .5 mL in 1 SYRINGE, GLASS (49281-326-88) TXT \| PDF \| XML \| JSON	49281-357-15 – Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) Firm: Sanofi Pasteur Inc. Package Description: 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-357-15) / 5 mL in 1 VIAL, MULTI-DOSE (49281-357-78) TXT \| PDF \| XML \| JSON
49281-926-50 – Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) Firm: Sanofi Pasteur Inc. Package Description: 10 SYRINGE, GLASS in 1 PACKAGE (49281-926-50) / .5 mL in 1 SYRINGE, GLASS (49281-926-88) TXT \| PDF \| XML \| JSON

19515-895-11 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 1 VIAL, MULTI-DOSE in 1 CARTON (19515-895-11) > 5 mL in 1 VIAL, MULTI-DOSE (19515-895-01) TXT \| PDF \| XML \| JSON	58160-900-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-900-52) > .5 mL in 1 SYRINGE (58160-900-41) TXT \| PDF \| XML \| JSON
19515-816-52 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 10 SYRINGE in 1 CARTON (19515-816-52) > .5 mL in 1 SYRINGE (19515-816-41) TXT \| PDF \| XML \| JSON	19515-818-52 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 10 SYRINGE in 1 CARTON (19515-818-52) > .5 mL in 1 SYRINGE (19515-818-41) TXT \| PDF \| XML \| JSON
58160-885-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-885-52) > .5 mL in 1 SYRINGE (58160-885-41) TXT \| PDF \| XML \| JSON	58160-887-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-887-52) > .5 mL in 1 SYRINGE (58160-887-41) TXT \| PDF \| XML \| JSON
19515-808-52 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 10 SYRINGE in 1 CARTON (19515-808-52) > .5 mL in 1 SYRINGE (19515-808-41) TXT \| PDF \| XML \| JSON	58160-890-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-890-52) / .5 mL in 1 SYRINGE (58160-890-41) TXT \| PDF \| XML \| JSON
19515-814-52 – Influenza Virus Vaccine Firm: ID Biomedical Corporation of Quebec Package Description: 10 SYRINGE in 1 CARTON (19515-814-52) / .5 mL in 1 SYRINGE (19515-814-41) TXT \| PDF \| XML \| JSON	58160-909-52 – Influenza Virus Vaccine Firm: GlaxoSmithKline Biologicals SA Package Description: 10 SYRINGE in 1 CARTON (58160-909-52) / .5 mL in 1 SYRINGE (58160-909-41) TXT \| PDF \| XML \| JSON
49288-0338-1 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 2 mL in 1 VIAL, MULTI-DOSE (49288-0338-1) TXT \| PDF \| XML \| JSON	49288-0338-2 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 5 mL in 1 VIAL, MULTI-DOSE (49288-0338-2) TXT \| PDF \| XML \| JSON
49288-0338-3 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0338-3) TXT \| PDF \| XML \| JSON	49288-0338-4 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 30 mL in 1 VIAL, MULTI-DOSE (49288-0338-4) TXT \| PDF \| XML \| JSON
49288-0338-5 – Northern Red Oak Firm: Antigen Laboratories, Inc. Package Description: 50 mL in 1 VIAL, MULTI-DOSE (49288-0338-5) TXT \| PDF \| XML \| JSON	49281-226-65 – Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) Firm: Sanofi Pasteur Inc. Package Description: 10 SYRINGE, GLASS in 1 PACKAGE (49281-226-65) / .7 mL in 1 SYRINGE, GLASS (49281-226-88) TXT \| PDF \| XML \| JSON
49281-326-50 – Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) Firm: Sanofi Pasteur Inc. Package Description: 10 SYRINGE, GLASS in 1 PACKAGE (49281-326-50) / .5 mL in 1 SYRINGE, GLASS (49281-326-88) TXT \| PDF \| XML \| JSON	49281-357-15 – Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) Firm: Sanofi Pasteur Inc. Package Description: 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-357-15) / 5 mL in 1 VIAL, MULTI-DOSE (49281-357-78) TXT \| PDF \| XML \| JSON
49281-926-50 – Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) Firm: Sanofi Pasteur Inc. Package Description: 10 SYRINGE, GLASS in 1 PACKAGE (49281-926-50) / .5 mL in 1 SYRINGE, GLASS (49281-926-88) TXT \| PDF \| XML \| JSON